Printed from Voxsanity (voxsanity.com.au) — NCT05042544 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.
Back to Hepatitis C
Hepatitis C Trial, Recruiting
NCT05042544
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years of age or older
- You have, or have had, at least one risk factor for getting Hepatitis C (HCV), such as: injecting drugs now or in the past, having been in prison, having HIV, receiving blood products before 1990, getting a tattoo or piercing in an unregulated setting, having a needle-stick injury, or having a mother with HCV
- OR you currently attend a service that supports people who may be at risk of Hepatitis C, such as a drug treatment clinic, needle and syringe program, prison, mobile outreach service, community health service, mental health service, or homelessness service
- You are willing and able to give your consent to take part in the study
Who may not be able to join:
- You are not able or not willing to give your consent to participate
- You are unwilling to follow the requirements of the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
Contact this trial
Phone: +61293850900
Australian sites
Hepatitis ACT, Canberra, Australian Capital Territory
Western NSW LHD, Bathurst, New South Wales
Far West LHD, Broken Hill, New South Wales
Maari Ma Health Aboriginal Corporation, Broken Hill, New South Wales
Galambila Aboriginal Health Service, Coffs Harbour, New South Wales
Central Coast LHD, Gosford, New South Wales
Armajun Health Service Aboriginal Corporation, Inverell, New South Wales
Rekindling the Spirit Health Service, Lismore, New South Wales
Asylum Seeker Centre, Newtown, New South Wales
Nepean Blue Mountains LHD, Penrith, New South Wales
North and Mid North Coast LHD, Port Macquarie, New South Wales
Walhallow Aboriginal Corporation, Quirindi, New South Wales
Bulgarr Ngaru Medical Aboriginal Corporation, South Grafton, New South Wales
Kirketon Road Centre, Sydney, New South Wales
NSLHD, Sydney, New South Wales
WSLHD Drug Health, Sydney, New South Wales
South West Sydney LHD, Sydney, New South Wales
Hepatitis NSW, Sydney, New South Wales
NSW Users and AIDS Association, Sydney, New South Wales
Prince of Wales Hospital, Sydney, New South Wales
SESLHD Community and Mental Health POCT Allicance (SCAMPA), Sydney, New South Wales
SESLHD Drug Health, Sydney, New South Wales
Storr Liver Clinic (Westmead Hospital), Sydney, New South Wales
Sydney Local Health District, Sydney, New South Wales
Murrumbidgee & Southern LHD, Wagga Wagga, New South Wales
Hunter New England LHD, Waratah, New South Wales
ISLHD Drug and Alcohol Service, Wollongong, New South Wales
ADSCA - Alice Springs Hospital, Alice Springs, Northern Territory
Clinic 34, Alice Springs, Northern Territory
Metro North HHS (Biala and Caboolture), Brisbane, Queensland
IHWH Micah Projects, Brisbane, Queensland
Cairns Sexual Health Service, Cairns, Queensland
Hepatitis QLD, Coorparoo, Queensland
Kombi Clinic, Inala, Queensland
Metro South Addiction Services - Inala AODS, Inala, Queensland
Ipswich AODS, Ipswich, Queensland
Ipswich Sexual Health and BBV Service, West Moreton Health, Ipswich, Queensland
OneBridge, Maroochydore, Queensland
North West HHS - Mount Isa ATODS, Mount Isa, Queensland
Sunshine Coast HHS AODS, Nambour, Queensland
Ethnic Communities Council of Queensland, West End, Queensland
Clinic H, Adelaide, South Australia
The Queen Elizabeth Hospital, Central Adelaide LHN, Adelaide, South Australia
Drug and Alcohol Services South Australia, Adelaide, South Australia
Lyell McEwin Hospital, North Adelaide LHN, Adelaide, South Australia
Flinders Medical Centre, South Adelaide LHN, Adelaide, South Australia
Hepatitis SA, Hackney, South Australia
Pangula Mannamurna Aboriginal Corporation, Mount Gambier, South Australia
Tasmanian Sexual Health Service - Clinic 60, Hobart, Tasmania
Moreton Group Rural Health, New Town, Tasmania
Ascot Vale Pharmacy, Ascot Vale, Victoria
Ballarat Community Health, Ballarat, Victoria
Harm Reduction Victoria, Brunswick, Victoria
Western Health, Footscray, Victoria
Eastern Health, Melbourne, Victoria
St Vincent's Hospital (Melbourne), Melbourne, Victoria
Youth Projects - The Living Room, Melbourne, Victoria
Latrobe Community Health Service Liited, Morwell, Victoria
Goulburn Valley Community Health, Shepparton, Victoria
Primary Care Connect, Shepparton, Victoria
Peer Based Harm Reduction Bunbury, Bunbury, Western Australia
South Terrace Clinic - Fremantle Hospital, Fremantle, Western Australia
Pramana Medical Centre, Gosnells, Western Australia
Plantagenet Medical, Mount Barker, Western Australia
Peer Based Harm Reduction - Perth, Perth, Western Australia
Hepatitis WA, Perth, Western Australia
Next Step East Perth, Perth, Western Australia
Next Step Fremantle, Perth, Western Australia
Next Step Warwick, Perth, Western Australia
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Status
Recruiting
Phase
Not Applicable
Sponsor
Kirby Institute
Registry
ClinicalTrials.gov
Start date
22 February 2022
Est. completion
30 June 2029
Where this trial is recruiting
🇦🇺 Australia
69 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
To evaluate the proportion of HCV infected (HCV RNA quantifiable) participants who initiate HCV treatment at 12 weeks following HCV RNA testing.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.
Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.